Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-15-000631
Filing Date
2015-01-13
Accepted
2015-01-13 17:14:46
Documents
11
Period of Report
2014-11-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q blud20141130_10q.htm 10-Q 2027019
2 EXHIBIT 31.1 ex31-1.htm EX-31 14713
3 EXHIBIT 31.2 ex31-2.htm EX-31 14915
4 EXHIBIT 32.1 ex32-1.htm EX-32 6124
5 EXHIBIT 32.2 ex32-2.htm EX-32 5031
  Complete submission text file 0001437749-15-000631.txt   17412089

Data Files

Seq Description Document Type Size
6 EXHIBIT 101.INS blud-20141130.xml EX-101.INS 3760960
7 EXHIBIT 101.SCH blud-20141130.xsd EX-101.SCH 62420
8 EXHIBIT 101.CAL blud-20141130_cal.xml EX-101.CAL 49265
9 EXHIBIT 101.DEF blud-20141130_def.xml EX-101.DEF 326978
10 EXHIBIT 101.LAB blud-20141130_lab.xml EX-101.LAB 398526
11 EXHIBIT 101.PRE blud-20141130_pre.xml EX-101.PRE 325061
Mailing Address 3130 GATEWAY DR P O BOX 5625 NORCROSS GA 30091-5625
Business Address 3130 GATWAY PO BOX 5625 NORCROSS GA 30091 770 441 2051
IMMUCOR INC (Filer) CIK: 0000736822 (see all company filings)

EIN.: 222408354 | State of Incorp.: GA | Fiscal Year End: 0531
Type: 10-Q | Act: 34 | File No.: 000-14820 | Film No.: 15525455
SIC: 2835 In Vitro & In Vivo Diagnostic Substances